Adam Kobayashi Selected Research

Adam Kobayashi Research Topics

30	Stroke (Strokes) 01/2021 - 01/2003
14	Ischemic Stroke 01/2020 - 11/2006
5	Atrial Fibrillation 01/2020 - 01/2005
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 10/2018
3	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2022 - 10/2018
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2017 - 08/2015
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021 - 03/2009
2	Carotid Stenosis (Carotid Artery Stenosis) 03/2020 - 05/2009
2	COVID-19 01/2020 - 01/2020
2	Infections 01/2020 - 01/2020
2	Hemorrhage 12/2019 - 01/2017
2	Hematoma 01/2018 - 11/2006
2	Hypertension (High Blood Pressure) 10/2015 - 03/2008
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Endocarditis 01/2020
1	Cerebral Hemorrhage 01/2018
1	Venous Thromboembolism 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015
1	Infarction (Infarctions) 08/2015
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 08/2015
1	Aneurysm (Aneurysms) 03/2009
1	Seizures (Absence Seizure) 02/2007

11	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2015 - 11/2006
9	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2021 - 09/2006
6	Dabigatran FDA Link 01/2022 - 01/2017
5	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 11/2015
5	AnticoagulantsIBA 01/2022 - 11/2013
5	Antihypertensive Agents (Antihypertensives)IBA 10/2015 - 03/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015 - 11/2013
2	Vitamin K FDA Link 10/2018 - 10/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2013 - 01/2005
2	Pharmaceutical PreparationsIBA 11/2013 - 12/2012
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	TroponinIBA 01/2020
1	vinyltriethoxysilane (VTES)IBA 12/2019
1	Heparin (Liquaemin)FDA LinkGeneric 10/2018
1	edoxabanIBA 01/2017
1	RivaroxabanIBA 01/2017
1	apixabanIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2013
1	2,6-dinitrotoluene (DNT)IBA 06/2012
1	Fibrinogen (Factor I)FDA Link 07/2011
1	NitratesIBA 03/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2008
1	Nitroglycerin (Dynamite)FDA LinkGeneric 03/2008
1	Blood Glucose (Blood Sugar)IBA 02/2007
1	Biological ProductsIBA 01/2005

5	Thrombectomy 01/2021 - 09/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2013
3	Stents 01/2021 - 03/2009
3	Therapeutics 12/2019 - 11/2006
3	Thrombolytic Therapy 03/2009 - 11/2006
2	Time-to-Treatment 12/2012 - 01/2012
1	Long-Term Care 01/2020
1	Decompression 01/2018
1	Punctures 09/2017
1	Contraindications 08/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2009
1	Embolectomy 09/2008
1	Estrogen Replacement Therapy 01/2003